Urology Today.net

Site updated at Wednesday, 20 May 2015

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



prostate cance1 - liver transplant1 - pain1 - johns hopkins university2 - nephron development1 - adequate erection1 - kidney blood pressure1 - postpartum depression1 - high cholesterol4 - testosterone6 - cardiovascular disease5 - prostatitis2 - renal vasoconstriction1 - female urethra1 - possible treatments1 - urinary tract imaging1 - adpkd3 - bph3 - genitourinary tract2 - resistant bacteria1 - creatinine test1 - thomas jefferson university hospital2 - recurrent bladder infection1 - overactive1 - albuminuria2 - focal glomerulosclerosis2 - prostate mri guidelines1 - prognostic indicator1 - microrna1 - cinacalcet1 -